Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Adult Vaccines Sector?

The market size for adult vaccines has seen significant growth in recent years. Projected growth indicates an increase from $22.82 billion in 2024 to $24.21 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be linked to factors such as a rising elderly population, government-led vaccination initiatives, heightened awareness of preventative health measures, advances in vaccine research and innovation, and public health promotional campaigns.

In the coming years, the adult vaccines market is projected to experience significant growth, possibly reaching a value of $34.19 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 9.0%. This upward trend over the forecast period can be linked to several factors such as the emergence of new infectious diseases, heightened attention on immunization registries, escalating concerns over antimicrobial resistance, global initiatives towards pandemic readiness, the move towards personalized vaccines, and an intensified focus on maternal immunization. Forecasted trends further include the integration of digital health, technological progress in vaccine production, partnerships between government entities and pharmaceutical firms, improvements in vaccine delivery technologies, and broader immunization programs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Forces Are Driving The Growth Of The Adult Vaccines Market?

The upward trend in the adult vaccine market is being propelled by the growing incidence of infectious diseases. These infectious diseases can be transmitted from one individual to another, and vaccines are a potent tool in combating these infections by enabling the individual to build immunity against them. For example, as per the Centers for Disease Control and Prevention, a public health agency based in the United States, the number of tuberculosis cases reported in 2022 rose to 8,300, up from 7,874 in 2021. Additionally, the TB incidence rate in 2022 saw a marginal rise, with 2.5 cases per 100,000 individuals compared to 2.4 in 2021. As such, the escalating frequency of infectious diseases is fueling the expansion of the adult vaccine market.

How Is The Adult Vaccines Industry Segmented Across Key Parameters?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

What Long-Term Trends Are Likely To Affect The Adult Vaccines Market?

One of the prominent trends emerging in the adult vaccines market is the introduction of novel products by leading companies. This approach is aimed at maintaining their market stance. For example, in August 2022, GSK, a bio-pharmaceutical corporation from the UK, and IQVIA, an Indian global firm offering advanced analytics, technology resolutions, and clinical research assistance, unveiled Vaccine Track. This data trend platform is designed to bolster the improvement of adult immunization across the nation. It will offer regular, pertinent data on trends, facilitating heightened attention and improvements in public health campaigns.

Which Companies Currently Dominate The Competitive Landscape In The Adult Vaccines Industry?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Geographic Regions Are Driving Demand In The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model